48,466
edits
Difference between revisions of "Medical kidney diseases"
Jump to navigation
Jump to search
m
→Fibrillary glomerulonephritis
m (→EM) |
|||
| Line 1,004: | Line 1,004: | ||
*[[AKA]] ''fibrillary glomerulopathy''. | *[[AKA]] ''fibrillary glomerulopathy''. | ||
===General=== | ===General=== | ||
*Rare ~ 1% native kidney biopsies.<ref name=pmid18045849>{{Cite journal | last1 = Alpers | first1 = CE. | last2 = Kowalewska | first2 = J. | title = Fibrillary glomerulonephritis and immunotactoid glomerulopathy. | journal = J Am Soc Nephrol | volume = 19 | issue = 1 | pages = 34-7 | month = Jan | year = 2008 | doi = 10.1681/ASN.2007070757 | PMID = 18045849 | URL = http://jasn.asnjournals.org/content/19/1/34.long }} | *Rare ~ 1% native kidney biopsies.<ref name=pmid18045849>{{Cite journal | last1 = Alpers | first1 = CE. | last2 = Kowalewska | first2 = J. | title = Fibrillary glomerulonephritis and immunotactoid glomerulopathy. | journal = J Am Soc Nephrol | volume = 19 | issue = 1 | pages = 34-7 | month = Jan | year = 2008 | doi = 10.1681/ASN.2007070757 | PMID = 18045849 | URL = http://jasn.asnjournals.org/content/19/1/34.long }}</ref> | ||
</ref> | |||
*Presents as [[nephrotic syndrome]]. | *Presents as [[nephrotic syndrome]]. | ||
*Prognosis poor; large number progress to ESRD. | *Prognosis poor; large number progress to ESRD. | ||
| Line 1,031: | Line 1,030: | ||
Note: | Note: | ||
*[[Amyloid]]: between 8 and 15 nm, most often 8-12 nm.<ref name=pmid18045849/> | *[[Amyloid]]: between 8 and 15 nm, most often 8-12 nm.<ref name=pmid18045849>{{Cite journal | last1 = Alpers | first1 = CE. | last2 = Kowalewska | first2 = J. | title = Fibrillary glomerulonephritis and immunotactoid glomerulopathy. | journal = J Am Soc Nephrol | volume = 19 | issue = 1 | pages = 34-7 | month = Jan | year = 2008 | doi = 10.1681/ASN.2007070757 | PMID = 18045849 | URL = http://jasn.asnjournals.org/content/19/1/34.long }}</ref> | ||
==Aristolochic acid nephropathy== | ==Aristolochic acid nephropathy== | ||